SXTC
China SXT Pharmaceuticals Inc
NASDAQ: SXTC · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$2.06
+0.49% today
Updated 2026-04-30
Market cap
$2.00M
P/E ratio
—
P/S ratio
1.30x
EPS (TTM)
$-57.15
Dividend yield
—
52W range
$1 – $368
Volume
0.1M
China SXT Pharmaceuticals Inc (SXTC) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-1,012.00%
ROE
-50.30%
ROA
-18.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2016 | $3.72M | $141544.00 | 21.35% | 5.62% | 3.81% |
| 2017 | $4.88M | $1.19M | 47.36% | 32.82% | 24.28% |
| 2018 | $7.02M | $1.19M | 48.46% | 23.25% | 16.92% |
| 2019 | $7.01M | $1.54M | 65.77% | 25.24% | 21.95% |
| 2020 | $5.16M | $-10.29M | 52.37% | -25.98% | -199.29% |
| 2021 | $4.78M | $-2.75M | 59.43% | -45.99% | -57.52% |
| 2022 | $2.60M | $-5.74M | 48.10% | -199.43% | -220.43% |
| 2023 | $1.97M | $-5.93M | 21.62% | -284.40% | -301.00% |
| 2024 | $1.93M | $-3.10M | 28.73% | -130.42% | -160.67% |
| 2025 | $1.74M | $-3.30M | 21.11% | -153.97% | -189.77% |